Indigenous communities in Latin America say they are missing out on life-saving HIV drugs due to a lack of representation.

An analysis by Li Tao, MD, MS, PhD, director of real-world evidence at Gilead Sciences, and colleagues looked at statistical ...

Lenacapavir is a long-acting pre-exposure prophylaxis (PrEP) product, a treatment that works by stopping HIV from getting ...

Harmony Garges, M.D, senior vice president, chief medical officer and head of global medical at ViiV Healthcare, highlighted ...

The increasing incidence of sexually transmitted bacterial infections (STIs) is a major public health problem worldwide.

The Global Landscape of National Civil Society Laws and Their Association With HIV 95-95-95 Indicators ... preventive measures like pre-exposure prophylaxis (PrEP). In fact, although many ...

HIV groups have criticised a decision not to recommend a long-acting injectable form of PrEP (Pre-exposure prophylaxis) to be made available ... and Care Excellence (NICE), the body that publishes ...

Second, our study used eligibility criteria for HIV post-exposure prophylaxis consistent with the DRC and WHO guidelines that emphasise the treatment of all rape survivors who are HIV negative or ...

Pre-exposure prophylaxis for the prevention of HIV infection: a systematic review for the U.S ... HIV Medicine Association of the Infectious Diseases Society of America. Guidelines for prevention and ...

and the release of the first U.S. guidelines for the use of post-exposure prophylaxis (PEP) in cases of accidental HIV exposure. Since 1999, only one confirmed case of occupationally-acquired HIV has ...